Trexquant Investment LP Neoleukin Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $83,805 - $254,826	-48,724 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.65 - $7.75 $67,071 - $111,786	14,424 Added 42.05%	48,724 $235,000
Q3 2021 Nov 12, 2021	BUY	$6.05 - $9.66 $121,538 - $194,059	20,089 Added 141.36%	34,300 $248,000
Q2 2021 Aug 12, 2021	BUY	$9.23 - $13.12 $131,167 - $186,448	14,211 New	14,211 $131,000
Q1 2021 May 13, 2021	SELL	$11.26 - $15.78 $136,752 - $191,648	-12,145 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$10.17 - $14.56 $123,514 - $176,831	12,145 New	12,145 $171,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.